It passes most of my checklist points. Considering it but dint buy because of the subdued revenue growth. While their direct competitor Gravita is growing at 25%, POCL is forecasting a 10% growth for 2 years running. Although they have big plans and targeting a 30% CAGR growth in revenues till 2030.
Will look at it again based on Q1 results or if the Lead cycle reverses and it impacts the margins.
Subscribe To Our Free Newsletter |